1. Department of Medicine, University of Cambridge, Cambridge, United Kingdom;
2. Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands;
3. Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom;
4. Great Ormond Street Hospital National Health Service Trust, London, United Kingdom;
5. University College London Genetics Institute, London, United Kingdom;
6. College of Applied Sciences, Al Baha University, Al Baha, Saudi Arabia;
7. University College London Institute of Immunity and Transplantation, London, United Kingdom;
8. Imagine Institute, University Paris Descartes Sorbonne Paris Cité, Paris, France;
9. INSERM UMR 1163, Paris, France;
10. Study Center for Primary Immunodeficiencies, Assistance Publique–Hôpitaux de Paris, Necker Hospital, Paris, France;
11. Department of Pediatric Immunology, Hematology and Rheumatology, Necker-Enfants Malades Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France;
12. Collège de France, Paris, France;
13. Human Lymphohaematopoiesis Laboratory, INSERM UMR 1163, Paris, France; and
14. Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom